$98.3 Million
Oncorus, Inc.
Initial Public Offering
Active Bookrunner
$253.6 Million
Accolade, Inc
Initial Public Offering
Passive Bookrunner
$57.0 Million
TELA Bio, Inc.
Initial Public Offering
Active Bookrunner
$92.0 Million
Oyster Point Pharma, Inc.
Initial Public Offering
Active Bookrunner
$167.4 Million
Phreesia Inc.
Initial Public Offering
Passive Bookrunner
$86.3 Million
NextCure, Inc.
Initial Public Offering
Left Bookrunner
$640.7 Million
Change Healthcare, Inc.
Initial Public Offering
Co-Manager
$209.3 Million
Health Catalyst, Inc.
Initial Public Offering
Passive Bookrunner
$408.5 Million
Livongo Health, Inc.
Initial Public Offering
Co-Manager
$400.8 Million
BridgeBio Pharma, Inc.
Initial Public Offering
Passive Bookrunner
Subscribe to United States

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.